The course is based on the CIIS program, adapted for the Australian context, and with input from MAPS, USONA, and others. It teaches therapists the research, therapy setting, risks, and therapeutic models for working with psychedelics.
Mind Medicine Australia
English
30 years
The Certificate in Psychedelic-Assisted Therapies (CPAT) by Mind Medicine Australia (MMA) is designed to meet the growing demand for trained therapists to provide regulatory-approved and research-backed psychedelic-assisted therapies for mental ill-health treatment in Australia. The course also prepares clinicians to work in research trials as they expand within the country.
Following world best practices, the CPAT is developed based on protocols from MAPS and the REBUS model by Imperial College London. The course aims to equip therapists with state change and stage change theory and technique, provide a theory of mind perspective, train therapists for future demands, help with the mental health crisis, contribute to changing attitudes and supporting legal changes, establish standards for safe and ethical practice, and bring together medical approaches with good psychotherapy standards and transpersonal aspects.
The CPAT program was developed through collaboration with experienced psychotherapists and incorporated live lectures, webcasts, self-study, and experiential workshops led by a skilled teaching team. The course respects the local context within Australia, making it the first program of its kind in the Southern Hemisphere.
Medical, Mental Health and Allied Health Professionals in Australia
The course has 4 assessment requirements:
Australian registered charity founded in 2019 that successfully campaigned for the Therapeutic Goods Administration (TGA) to reschedule psilocybin and MDMA in 2023 — making Australia the first country to formally approve these substances for clinical use. MMA trains clinicians through its Certificate in Psychedelic-Assisted Therapies (CPAT) program, funds clinical trials, and has supplied medicines and training to 100+ patients under the TGA Authorised Prescriber scheme.
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
By Therapsil
Focused short-form trainings in psychedelic safety, harm reduction, and clinical skill. One listed topic is Psychedelic First Aid, presented in collaboration with Neuma Centre.
Next cohort: May 20, 2026